We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

142 hedge funds and large institutions have $354M invested in Alaunos Therapeutics in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 32

10% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 20

1% more funds holding

Funds holding: 140 → 142 (+2)

0.05% more ownership

Funds ownership: 0.29% → 0.34% (+0.05%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less capital invested

Capital invested by funds: $409M → $354M (-$55.3M)

36% less call options, than puts

Call options by funds: $6.68M | Put options by funds: $10.5M

Holders
142
Holders Change
+2
Holders Change %
+1.43%
% of All Funds
3.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
48
Reduced
32
Closed
20
Calls
$6.68M
Puts
$10.5M
Net Calls
-$3.81M
Net Calls Change
+$1.08M

Top Buyers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
+$22M
2
MVP
Miller Value Partners
Florida
+$19.8M
3
State Street
State Street
Massachusetts
+$8.3M
4
DCM
Discovery Capital Management
Connecticut
+$7.61M
5
BlackRock
BlackRock
New York
+$2.81M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$2.6M
2
SG Americas Securities
SG Americas Securities
New York
-$2.21M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.29M
4
Barclays
Barclays
United Kingdom
-$589K
5
CSS
Cubist Systematic Strategies
Connecticut
-$564K
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
MSD Partners
New York
$64.8M +$22M +27,768 +38%
MVP
2
Miller Value Partners
Florida
$55.6M +$19.8M +24,960 +41%
BlackRock
3
BlackRock
New York
$52.6M +$2.81M +3,536 +5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$47.8M -$436K -550 -0.7%
State Street
5
State Street
Massachusetts
$30.4M +$8.3M +10,457 +28%
DCM
6
Discovery Capital Management
Connecticut
$17.9M +$7.61M +9,598 +52%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$8.93M +$430K +542 +4%
Northern Trust
8
Northern Trust
Illinois
$8.75M +$1.73M +2,180 +19%
Morgan Stanley
9
Morgan Stanley
New York
$7.1M +$1.44M +1,820 +20%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$4.5M +$16.7K +21 +0.3%
Charles Schwab
11
Charles Schwab
California
$4.18M +$414K +522 +9%
UBS Group
12
UBS Group
Switzerland
$4.05M +$2.07M +2,615 +71%
N
13
Nuveen
North Carolina
$3.15M +$216K +272 +6%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$2.77M +$3.97K +5 +0.1%
Rafferty Asset Management
15
Rafferty Asset Management
New York
$1.65M +$972K +1,225 +91%
Citigroup
16
Citigroup
New York
$1.63M -$373K -470 -16%
Group One Trading
17
Group One Trading
Illinois
$1.54M +$341K +430 +22%
Goldman Sachs
18
Goldman Sachs
New York
$1.42M +$891K +1,123 +103%
CB
19
Commerce Bank
Missouri
$1.3M – – –
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$1.27M +$407K +513 +35%
VIA
21
Vident Investment Advisory
Georgia
$1.16M -$40.5K -51 -3%
Swiss National Bank
22
Swiss National Bank
Switzerland
$1.11M +$21.4K +27 +2%
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$1.07M +$15.1K +19 +1%
Millennium Management
24
Millennium Management
New York
$1.07M -$524K -660 -28%
Federated Hermes
25
Federated Hermes
Pennsylvania
$1.07M +$1.24M +1,568 +1,600%
1
2 3 4 5

TCRT Hedge Fund Activity: Q3 2019 in Review

142 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q3 2019, worth a combined $354M — down 14% from $409M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TCRT positions and 20 closed out — a net gain of 2 holders — while 48 added to existing stakes and 32 trimmed.

The largest buyer was MSD Partners, adding an estimated $22M. The largest seller was Invesco, exiting entirely with an estimated $2.6M sold.

  • 142 institutional investors held Alaunos Therapeutics (TCRT) as of Q3 2019, up from 140 in Q2 2019.
  • Funds reported $354M of Alaunos Therapeutics stock for Q3 2019, down 14% quarter-over-quarter.
  • 22 funds opened new Alaunos Therapeutics positions in Q3 2019 and 20 closed out, a net change of +2 holders.
  • The largest Alaunos Therapeutics buyer in Q3 2019 was MSD Partners, an estimated $22M added.
  • The largest Alaunos Therapeutics seller in Q3 2019 was Invesco, an estimated $2.6M sold.

Based on aggregated 13F filings for Q3 2019.